Orca Bio Appoints Nate Fernhoff As Chief Executive Officer

May 13, 2025•3 months ago

Position

Chief Executive Officer

Company

Orca Bio

Nate Fernhoff

Menlo ParkTherapeuticsBiotechnologyHealth Care

Description

Orca Bio has announced the appointment of Nate Fernhoff, Ph.D., as Chief Executive Officer, succeeding Ivan Dimov, Ph.D. Jeroen Bekaert, Ph.D., has been appointed as President, further strengthening the company's leadership team.

Company Information

Company

Orca Bio

Location

Menlo Park, California, United States

About

Orca Bio is a late-stage biotechnology company dedicated to transforming the lives of patients through high-precision cell therapy. The company is focused on developing innovative T-cell immunotherapies for the treatment of blood cancers. Their lead investigational products, Orca-T and Orca-Q, are currently being evaluated in pivotal clinical trials. Orca Bio aims to deliver high-precision therapies to patients who could greatly benefit from improved treatment options.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months